New FDA Approval: Ozempic Gets Nod For Kidney Protection In Type 2 Diabetes
The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...
What Happens to Your Body When You Eat Grapefruit Regularly
Like pretty much all fruits and vegetables, grapefruit can help improve your health in many ways. It’s packed with vitamins, minerals, antioxidants and other plant compounds that do a body good. Let’s ...
GlobalData on MSN10h
Beta Bionics raises $204m to kickstart medtech IPO season
Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common ...
Knowridge1d
Diabetes and obesity can damage the liver to the point of failure – but few people know their risk of developing liver disease
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...
devdiscourse2d
From Drug Approvals to Global Health Funding: Key Updates in Health Sector
This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...
Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP™) Development Using iPSCs
Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...
5 Key Insights On Dexcom’s Stelo And Abbott’s Lingo Glucose Monitors
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
Mounjaro menu plan: What foods to eat and avoid for optimal results
Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...
Beta Bionics, Inc. (BBNX) Announces January 30th IPO
Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...
PBS5d
The FDA banned Red 3 food coloring. A scientist explains the dye’s history and health risks
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
localnewsmatters11d
Newsom committed California to making its own insulin. It’s a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced ...
BioPharma Dive13d
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.